Skip to main content
. 2020 Nov 18;6(1):1–8. doi: 10.1001/jamacardio.2020.5573

Table 3. Univariable and Multivariable Cox Proportional HRs for Incident Cardiovascular Disease Events for Carotid Artery Magnetic Resonance Imaging Plaque Burden Variables and Categorical Plaque Characteristics (N = 1256).

Variable (per 1-unit increment in ln-transformed continuous variables or dichotomous)a,b Univariable HR Adjusted for clinical factorsc Adjusted for carotid thicknessd
HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
Carotid artery plaque burdena
Lumen area 0.68 (0.44-1.06) .09 0.63 (0.42-0.94) .02 NA NA
Wall area 1.79 (1.12-2.87) .02 1.14 (0.66-1.97) .64 NA NA
Total wall volume 1.97 (1.19-3.28) .009 1.29 (0.69-2.44) .43 NA NA
Maximum carotid artery wall thickness 1.54 (1.01-2.37) .05 1.21 (0.76-1.92) .42 NA NA
Normalized wall index 2.10 (1.04-4.26) .04 1.75 (0.85-3.60) .13 NA NA
Max stenosis 1.32 (1.16-1.50) <.001 1.23 (1.07-1.42) .004 NA NA
Categorical carotid artery plaque characteristicsb
Presence of lipid core 2.39 (1.61-3.54) <.001 1.92 (1.22-3.04) .005 2.48 (1.36-4.51) .003
Presence of lipid core in ≥2 adjacent slices 2.43 (1.63-3.64) <.001 1.86 (1.18-2.95) .008 2.28 (1.29-4.02) .005
Presence of calcification 1.86 (1.24-2.80) .003 1.44 (0.93-2.24) .11 1.45 (0.78-2.73) .24
Presence of intra plaque hemorrhage 1.49 (0.82-2.70) .19 1.16 (0.62-2.16) .65 NA NA

Abbreviations: HR, hazard ratio; ln, natural log; NA, not applicable.

a

Hazard ratios are per 1-unit increment in ln-transformed continuous plaque burden variables. All plaque burden variables were ln-transformed. eTable 9 in the Supplement shows details for the conversion between original values and ln-transformed values for continuous carotid magnetic resonance imaging variables.

b

Hazard ratio is for presence vs absence.

c

Adjusted for clinical factors: age, sex, race/ethnicity, and Atherosclerosis Risk in Communities study field center, smoking, body mass index, blood glucose level, diabetic status, systolic blood pressure, diastolic blood pressure, high-density lipoprotein cholesterol, non–high-density lipoprotein cholesterol, use of blood pressure–lowering medication, cholesterol-lowering medication use, aspirin use, diabetes medication use, and high-sensitivity C-reactive protein.

d

Adjusting for carotid thickness (for analyses involving lipid rich core, calcification, and fibrous cap measures only): adjusted for clinical factors plus maximum carotid artery wall thickness.